Site navigation
Our sites
As the coronavirus spread globally in 2020, and people all around the world began to be uncomfortably familiar with RAT tests and PCR tests, NSW historian Michelle Bootcov realised her …
The incidence of primary liver cancer in Australia has quadrupled since 1982—faster than any other cancer. Yet, the 5-year survival remains just 22%, in stark contrast to countries like Japan, …
When we at Hepatitis SA talk with members of the community about hepatitis C treatment, we usually point out that the current available cure works for more than 95% of …
A study recently published by a gastroenterology research team in India, has identified a new ”phobia’ in people who have been cured of hepatitis C – the fear of reinfection. …
Two different experimental hepatitis B virus (HBV) treatments have shown very different results in their phase 2 trials in recent weeks. One, while initially promising, has failed to show high …
Former Labor senator Pat Dodson, sometimes called ‘the Father of Reconciliation’, has emerged from a self-imposed silence to urge the prime minister to take up the cause once more with …
Despite having all the tools to combat liver cancer, a lack of prioritisation and action has resulted in an increase in mortality worldwide. These deaths are entirely preventable if people …
New titles added in April include: Hepatitis B and hepatitis C mapping reports, Close the Gap campaign annual report, Human Rights and drug policy report...
Studies have shown a higher rate of congenital heart disease in infants born to parents with hepatitis B.
With the rise of measles in the US, it's useful to know that measles can cause liver dysfunction.
Hepatitis SA is backing Hepatitis Australia’s call for universal hepatitis B (HBV) testing, after new data confirmed the silent role of chronic hepatitis B in Australia’s rising liver cancer deaths, …
Despite the rejection of the Voice in the 2023 referendum, some working in the sector still see hope.
The 2025-26 Federal Budget–showing the Labor government’s plans if re-elected in May–has an emphasis on public health investment, focused on strengthening primary care and improving access to PBS-listed medicines. The …
The Australian Pharmaceutical Benefits Scheme (PBS) has recently rejected an application for a new drug, bulevirtide, to be available at subsidised rates for treatment of hepatitis D, despite submissions from …
In southern Pakistan’s Sindh province, on the edge of Karachi’s bustling fish harbour, sits an informal settlement where life is harsh.
Unlike a number of other viruses, hepatitis C (HCV) is only naturally found–and able to replicate–in humans and, to a lesser extent, chimpanzees. This has proven to be a major …
Meatless alternatives to meat are an increasingly viable option for people looking to improve their own health, the planet’s health, or reduce the amount of suffering in the world. People …
A new and promising approach to developing a vaccine for hepatitis Chas been uncovered by medical research scientists in Germany.
Hepatitis B, C and D rely on a common factor for replication. This could be used to develop a cure for all three viruses.
A research discovery from the Storr Liver Centre at the Westmead Institute for Medical Research in Sydney has identified why lean people with metabolic dysfunction-associated fatty liver disease (MAFLD) have …
Burnet study finds introducing hepatitis C outreach and treatment programs in Australian community pharmacies could significantly increase testing and cure.
One significant contrast between the two most damaging viral hepatitis viruses is that hepatitis B can be vaccinated against, but the is no reliable cure. Hepatitis C, on the other …
Globally, fewer than 10 per cet of the people living with hepatitis B (HBV) have been diagnosed. With only a little over five years until the deadline for the World …
Man-made environmental pollution is known as a significant danger to human health. Globally, air pollution kills more than 8 million people annually, and the particulate matter caused by Australia’s climate …
May 2025
